Adverse events of iron and/ or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review
Date
2022-10-27
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central Ltd
Abstract
Background
Iron supplementation and erythropoiesis-stimulating agent (ESA) administration represent the hallmark therapies in preoperative anemia treatment, as reflected in a set of evidence-based treatment recommendations made during the 2018 International Consensus Conference on Patient Blood Management. However, little is known about the safety of these therapies. This systematic review investigated the occurrence of adverse events (AEs) during or after treatment with iron and/or ESAs.
Description
The original publication is available at: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02081-5
Keywords
Citation
Laermans, J. et al. 2022. Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review. Syst Rev 11(224):17 pages . doi.10.1186/s13643-022-02081-5